Cleared Traditional

II-Type Intervertebral Spacer (K180228) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180228 · Paonan Biotech Co., Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
350d
Days
Class 2
Risk

K180228 is an FDA 510(k) clearance for the II-Type Intervertebral Spacer. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Paonan Biotech Co., Ltd. (Taipei, TW). The FDA issued a Cleared decision on January 11, 2019 after a review of 350 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Paonan Biotech Co., Ltd. devices

Submission Details

510(k) Number K180228 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2018
Decision Date January 11, 2019
Days to Decision 350 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
228d slower than avg
Panel avg: 122d · This submission: 350d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 464
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K180228.
Neo Cage System TM
K181048 · Neo Medical SA · Jan 2019
VariLift-LX Interbody Fusion System, VariLift-C Interbody Fusion System
K180822 · Wenzel Spine, Inc. · Jan 2019
NEST Interbody System
K180230 · Paonan Biotech Co., Ltd. · Jan 2019
FlareHawk Interbody Fusion System
K182114 · Integrity Implants, Inc. · Jan 2019
TiWAVE-L Porous Titanium Lumbar Cage
K182210 · Kalitec Medical, LLC · Jan 2019
Curiteva Lumbar Interbody Fusion System
K181589 · Curiteva, LLC · Dec 2018